School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
PLoS One. 2012;7(1):e30096. doi: 10.1371/journal.pone.0030096. Epub 2012 Jan 10.
Insulin and the insulin-like growth factor (IGF) system regulate growth and are involved in determining muscle mass, strength and body composition. We hypothesised that IGF-I and IGF-II are associated with improved, and insulin with worse, physical performance in old age.
Physical performance was measured using the get-up and go timed walk and flamingo balance test at 63-86 years. We examined prospective associations of insulin, IGF-I, IGF-II and IGFBP-3 with physical performance in the UK-based Caerphilly Prospective Study (CaPS; n = 739 men); and cross-sectional insulin, IGF-I, IGF-II, IGFBP-2 and IGFBP-3 in the Boyd Orr cohort (n = 182 men, 223 women).
In confounder-adjusted models, there was some evidence in CaPS that a standard deviation (SD) increase in IGF-I was associated with 1.5% faster get-up and go test times (95% CI: -0.2%, 3.2%; p = 0.08), but little association with poor balance, 19 years later. Coefficients in Boyd Orr were in the same direction as CaPS, but consistent with chance. Higher levels of insulin were weakly associated with worse physical performance (CaPS and Boyd Orr combined: get-up and go time = 1.3% slower per SD log-transformed insulin; 95% CI: 0.0%, 2.7%; p = 0.07; OR poor balance 1.13; 95% CI; 0.98, 1.29; p = 0.08), although associations were attenuated after controlling for body mass index (BMI) and co-morbidities. In Boyd Orr, a one SD increase in IGFBP-2 was associated with 2.6% slower get-up and go times (95% CI: 0.4%, 4.8% slower; p = 0.02), but this was only seen when controlling for BMI and co-morbidities. There was no consistent evidence of associations of IGF-II, or IGFBP-3 with physical performance.
There was some evidence that high IGF-I and low insulin levels in middle-age were associated with improved physical performance in old age, but estimates were imprecise. Larger cohorts are required to confirm or refute the findings.
胰岛素和胰岛素样生长因子(IGF)系统调节生长,并参与决定肌肉质量、力量和身体成分。我们假设 IGF-I 和 IGF-II 与老年时身体机能的改善有关,而胰岛素与身体机能的恶化有关。
使用起身行走和火烈鸟平衡测试在 63-86 岁时测量身体机能。我们在英国卡菲利前瞻性研究(CaPS;n=739 名男性)中检验了胰岛素、IGF-I、IGF-II 和 IGFBP-3 与身体机能的前瞻性关联;并在 Boyd Orr 队列(n=182 名男性,223 名女性)中检验了胰岛素、IGF-I、IGF-II、IGFBP-2 和 IGFBP-3 的横断面关联。
在混杂因素调整模型中,CaPS 中有些证据表明,IGF-I 的标准差(SD)增加与起身行走测试时间快 1.5%相关(95% CI:-0.2%,3.2%;p=0.08),但与 19 年后的平衡能力较差相关不大。Boyd Orr 的系数与 CaPS 的方向相同,但与机会一致。较高的胰岛素水平与较差的身体机能呈弱相关(CaPS 和 Boyd Orr 联合:起身行走时间每 SD 对数转换胰岛素慢 1.3%;95% CI:0.0%,2.7%;p=0.07;OR 平衡能力差 1.13;95% CI;0.98,1.29;p=0.08),但在控制体重指数(BMI)和合并症后,相关性减弱。在 Boyd Orr 中,IGFBP-2 的 SD 增加与起身行走测试时间慢 2.6%相关(95% CI:0.4%,4.8%慢;p=0.02),但仅在控制 BMI 和合并症时才如此。IGF-II 或 IGFBP-3 与身体机能之间没有一致的关联证据。
有一些证据表明,中年时 IGF-I 水平较高和胰岛素水平较低与老年时身体机能的改善有关,但估计值不够准确。需要更大的队列来证实或反驳这些发现。